Arrowhead Pharmaceuticals Inc (ARWR) — Cash Flow Reinvestment Rate
Arrowhead Pharmaceuticals Inc (ARWR) has a Cash Flow Reinvestment Rate of 4.27x as of September 2025, reinvesting $87.60 Million (capex $7.49 Million plus investments $80.11 Million) from operating cash flow of $20.49 Million. Explore Arrowhead Pharmaceuticals Inc capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Arrowhead Pharmaceuticals Inc Cash Flow Reinvestment Rate (1997–2025)
Historical reinvestment intensity for Arrowhead Pharmaceuticals Inc across 4 annual periods. Also explore Arrowhead Pharmaceuticals Inc assets under control for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Arrowhead Pharmaceuticals Inc (1997–2025)
Year-by-year capital reinvestment analysis for Arrowhead Pharmaceuticals Inc. For live market cap and broader valuation context, see how much is Arrowhead Pharmaceuticals Inc worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.85x | $151.96 Million | $179.55 Million | $22.67 Million | ▲ +2.3% |
| 2021 | 0.83x | $141.68 Million | $171.22 Million | $23.57 Million | ▲ +139.6% |
| 2019 | 0.35x | $59.75 Million | $173.03 Million | $12.00 Million | — |
| 1997 | 0.00x | $0.00 | $4.56K | $0.00 | — |